Are You Ready to See Pharmacy in a Whole New Light?

SPONSORED CONTENT

The future of health system pharmacy is moving beyond acute care. On October 11, join Omnicell for an exclusive virtual event as we unveil the next evolution of medication management.

We’re bringing together some of the brightest minds in healthcare to explore new opportunities to drive value and enhance outcomes across

Read More »

Judge Issues Stay in Merck’s 340B Contract Pharmacy Lawsuit

Merck wordmark on office building windows
A federal district judge in Washington, D.C., put drug manufacturer Merck’s 340B contract pharmacy lawsuit against the federal government on hold pending a related federal appeals court decision.

A federal district judge in Washington, D.C., put drug manufacturer Merck’s 340B contract pharmacy lawsuit against the federal government on hold until after a federal circuit court in Washington rules in Novartis and United Therapeutics’ 340B contract pharmacy cases.

Lawyers

Read More »

340B Provider Groups Decry Federal Judge’s PrEP Coverage Decision

PrEP pill
340B HIV provider groups have condemned a federal court decision that mandating private health insurance coverage of PrEP, a daily medication used to prevent HIV infection, is unconstitutional.

340B HIV provider groups have slammed a recent federal court decision that could have far-reaching implications on access to a host of preventive health care services.

On Sept. 7, Judge Reed O’Connor of the United States District Court for the

Read More »

Navigating the 340B Program for Maximum Benefits and Guaranteed Compliance

SPONSORED CONTENT

If you are reading this article, then you’re likely aware of the 340B drug discount program, the U.S. federal government program that requires drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices.

Covered entities may effectively navigate this incredibly complex program, maximize their benefits, reach more eligible patients, and maintain compliance with a new

Read More »

Federal Appeals Court Will Hear Arguments in Lilly’s 340B Contract Pharmacy Suit on Oct. 31

Eli Lilly wordmark
A federal appeals court will hear arguments in Lilly's 340B contract pharmacy lawsuit on Oct. 31.

A federal appeals court in Chicago will hear oral arguments in drug manufacturer Eli Lilly’s 340B contract pharmacy lawsuit against the federal government on Oct. 31, the court announced on Tuesday.

The half-hour session will take place one week after

Read More »

CMS Gets Conflicting Advice About Unwinding Drug Payment Cuts for 340B Hospitals

outpatient surgery center entrance sign on building facade
Stakeholders offered CMS conflicting advice about how to reverse a nearly 30% cut in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs since 2018. | Flickr.com/photos/rxb

Key stakeholders have offered federal healthcare officials conflicting advice about how best to respond to the U.S. Supreme Court’s June decision striking down a nearly 30% cut in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.

Tuesday was the

Read More »

Unichem Says 340B Audit Found it Overcharged Just Two Entities and Must Repay Them Just $110.20

Drug manufacturer Unichem wordmark on building
Generic drug manufacturer Unichem says a 340B compliance audit found it overcharged just two entities and the repayment to both totals just $110.20.

Late last month, the U.S. Health Resources and Services Administration (HRSA) said on its website that generic drug manufacturer Unichem Pharmaceuticals USA had to repay 340B covered entities for overcharges found during a 340B program compliance audit.

According to Unichem,

Read More »

U.S. Uninsured Rate Dipped Last Year, Census Bureau Says

bar charts depicting percent of people by health insurance coverage type and change from 2020 to 2021
The U.S. uninsured rate declined slightly in 2021 to 8.3%, the U.S. Census Bureau reported this week.

About 8.3% of people in the United States, or 27.2 million, had no health insurance at any point during 2021, down from an estimated 8.6%, or 28.3 million, in 2020, the U.S. Census Bureau reported Tuesday.

The National Center for

Read More »

Judge Dismisses 340B Contract Pharmacy-Related Antitrust Claims Against Insulin Manufacturers

Federal District Court Rochester, N.Y. entrance and building-mounted sign
A federal district judge in Rochester, N.Y., has dismissed two community health centers’ antitrust suit against insulin manufacturers over the companies’ 340B pricing policies.

A federal district judge has dismissed two community health centers’ federal and state antitrust claims against four insulin and diabetes drug manufacturers over the companies’ denials of 340B pricing when covered entities use contract pharmacies.

Chief Judge Elizabeth Wolford of

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report